Minimally Invasive Hemodynamic Monitoring in Intensive Care Unit. A Brief Review by Anninos, Hector & Manolis, Antonis S
28 
 
REVIEW      Rhythmos 2015;10(2):28-33 
 
Minimally Invasive Hemodynamic Monitoring in 
Intensive Care Unit. A Brief Review  
Hector Anninos, MD, Antonis S. Manolis, MD 
First Cardiology Department, Evagelismos Hospital, 
Athens, Greece; e-mail: ekanninos@yahoo.com   
Abstract 
To avoid use of a Swan-Ganz catheter and its attendant 
complications, new technologies have now become 
available to help the clinician perform a less invasive 
hemodynamic monitoring in patients in the intensive care 
unit (ICU). Among these, conventional echocardiography, 
the esophageal Doppler, pulse pressure analysis, the 
transpulmonary thermodilution, the indicator dilution and 
the thoracic electrical bioimpedance and bioreactance, all 
aim at measuring stroke volume and cardiac output by less 
invasive means and they are herein briefly reviewed.  
Key Words: hemodynamic monitoring; cardiac output; stroke 
volume; echocardiography; Doppler  
Abbreviations: CO = cardiac output; CVP = central venous 
pressure; ICU = intensive care unit; PAC = pulmonary artery 
catheter; SV = stroke volume; VTI = velocity time integral   
Introduction 
Multi-organ dysfunction commonly seen in critically ill 
patients as a consequence of systemic inflammatory 
response syndrome or sepsis, is mediated by an imbalance 
between oxygen delivery and demand, which inevitably 
leads to tissue hypoxia and shock. In this pathophysiologi-
cal procedure, circulatory parameters such as preload, 
afterload and myocardial contractility play a cardinal role. 
Traditionally, vital signs, physical findings, central venous 
pressure, arterial oxygen saturation and urine output have 
been used to assess volume status and tissue oxygenation. 
The need for early hemodynamic assessment and 
consequent strict goal-directed specific treatment has been 
recognized since 2001 and it has been shown to provide 
better outcomes in septic patients.1 Unfortunately, the 
aforementioned variables do not change significantly in 
the early stages of shock, and are not considered suitable 
for advanced hemodynamic evaluation.2 Volume 
replacement is usually the first step in resuscitation; 
however not all hemodynamically unstable patients are 
volume-responsive, and fluid overload can have deleteri-
ous effects.3 Thus, the aim of the hemodynamic assessment 
would be to recognize volume depletion (cardiac preload 
estimation) and predict the response to fluid 
administration. The desirable outcome of such an action is 
increase of stroke volume (SV) and cardiac output (CO).  
Therefore, monitoring of these parameters can provide 
the most reliable information. After the introduction of 
pulmonary artery catheter (PAC) by Swan and Ganz in the 
1970s, which could obtain reliable intracardiac pressure 
and CO measurements, right heart catheterization 
dominated clinical practice until the mid 1990s, when 
Connors et al reported increased mortality related to the 
PAC use in the ICU setting.4 Since then, several minimally 
invasive or non-invasive methods to measure CO and 
evaluate other hemodynamic parameters in order to assess 
volume status or predict fluid responsiveness have 
emerged, each trying to find a place in everyday routine of 
ICUs. Namely, they include the esophageal Doppler, the 
conventional echocardiography, the pulse pressure 
analysis, the transpulmonary thermodilution, the indicator 
dilution and the thoracic electrical bioimpedance and 
bioreactance and they will be briefly discussed here.  
Non-invasive modalities  
Esophageal Doppler 
From the mid-esophageal descending aorta long axis 
view one can measure the blood flow velocity. The CO 
calculation requires the aortic diameter which can be either 
measured or estimated on the basis of physical 
characteristics of the specific person, and takes into 
account the distribution of blood to the descending aorta.5 
Although readily available, this method has some 
significant limitations. Firstly, it can be technically 
demanding with regard to the proper image acquisition. 
Moreover, the aortic diameter may vary over time, 
influenced by vascular tone, aortic compliance or 
vasopressor use, and the assumption that descending aorta 
receives a predetermined part of stroke volume may 
introduce considerable error in the measurement.6 
However, esophageal Doppler is reliable in detecting 
changes in CO 7 and it has been shown to provide 
morbidity benefit when used to guide fluid administration 
in the operating theatre. 8-10  
Transthoracic echocardiography 
Conventional and novel techniques can provide 
valuable information of left and right ventricular function, 
inferior vena cava dimensions which serve as a measure of 
preload and CO approached by calculating the velocity-
time integral (VTI) of left ventricular outflow tract. 11-12   
Pulse contour analysis 
Several systems which compute SV and CO based on 
the waveform of arterial pressure have been developed. All 
use algorithms that incorporate assumptions of systemic 
vascular resistance and arterial compliance to produce a 
realistic pressure-volume relationship. The central 
hypothesis states that SV is proportional to the arterial 
pulse pressure 13 and although aortic compliance is a non-
linear function of blood pressure, SV is calculated from the 
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area under the curve of the systolic portion of the arterial 
waveform (Fig. 1.) with the use of sophisticated 
mathematical methods.14 It is obvious that in order to 
guarantee the reliability of measurements, the arterial 
pressure tracing must be optimal and that conditions that 
affect the relationship between pulse pressure and SV 
(aortic regurgitation, intra-aortic balloon counterpulsation) 
will interfere and modify the results. 15  
The commercially available systems fall into 3 catego-
ries: (1) systems that require demographic and somato-
metric data to estimate arterial impedance, (2) systems that 
require no additional information and (3) systems that 
require periodic calibration by objective CO measurement 
using thermodilution or indicator dilution method.  
 Figure 1. Area under the curve of systolic part of arterial 
waveform is used to obtain stroke volume measurement   
Uncalibrated devices 
The FloTrac system includes a sensor connected to the 
Vigileo monitor. It obtains the arterial pulse signal from an 
indwelling arterial catheter, irrespective of its position, and 
calculates the SV and subsequently the CO assuming a 
linear relationship between SV and pulse pressure. The 
raw data, produced by arterial waveform sampling, are 
corrected with respect to arterial compliance, mean arterial 
pressure and waveform characteristics, by a conversion 
factor. Arterial compliance is estimated using 
demographic and somatometric values. Waveform 
features to be evaluated are skewness (asymmetry) and 
kyrtosis (peakedness) and are thought to represent changes 
in vascular tone. The system’s reliability has been tested 
against the presumed gold standard (pulmonary catheter 
thermodilution) and the latest upgraded third generation 
editions proved more trustworthy than the previous ones. 
However, its accuracy fades away when the patient 
receives substantial amounts of vasopressors and it does 
not detect accurately the changes in SV after a fluid 
challenge.6, 16-18 In a clinical trial, the early use of FloTrac 
system in hemodynamically unstable ICU patients neither 
led to faster stabilization nor improved outcome. 19 These 
weaknesses may have been overcome by the 4th generation 
devices but more trials are necessary to allow for 
conclusive statements. 20 
The MostCare system needs no additional data and 
determines SV by measuring the area under the curve 
during the whole cardiac cycle. This method is called 
Pressure recording analytical method (PRAM). The device 
disintegrates the waveform into its systolic and diastolic 
phase identifying the dicrotic notch and then determines 
the contribution of each phase and calculates two 
impedances. This procedure, with the use of advanced 
mathematical algorithms allows for an internal calibration 
as the elastic properties of the arteries can be approximated 
instantaneously by the waveform analysis. 21 Although an 
easy and minimally invasive method, its evaluation against 
the standard techniques has yielded conflicting results, 
with most weaknesses appearing when applied on 
hemodynamically unstable patients. 22-29  
A new entry in the area of non-invasive CO monitoring 
is the Nexfin monitor. The device consists of an inflatable 
cuff which is placed around the middle phalanx of a finger 
and connected to the monitor. The cuff retains the volume 
of the finger constant by applying the appropriate amount 
of pressure continuously, thus producing a pressure 
waveform. This finger artery pressure is then used to 
deduce the brachial artery waveform, using coefficients 
which are derived from extensive clinical data. The 
method has been evaluated during cardiac surgery and in 
the emergency department and its comparison with 
echocardiographic methods and transpulmonary thermo-
dilution has yielded promising results. Interestingly, it 
seems to maintain its reliability in cases of vasopressor 
administration. In critically ill patients, it can measure 
blood pressure with acceptable accuracy compared to 
invasive systems but showed moderate correlation with 
transpulmonary thermodilution in estimation of CO.  30-36   
Calibrated devices  
These systems perform continuous measurement of 
arterial pressure, SV and CO by analyzing the arterial 
pressure waveform obtained from a peripheral or 
preferably central arterial line, and recalibrate 
intermittently using an indicator dilution or thermodilution 
method. The LiDCO technology utilizes the lithium 
dilution technique (Fig. 2). A certain amount of lithium 
chloride (0.5-2 mL) is injected through a peripheral or 
central line and the lithium concentration is measured at 
the arterial catheter site, using a Li+-sensitive electrode. 
This electrode traces other monovalent cations as well, 
such as sodium, and hence a correction factor with respect 
to sodium plasma levels is used. Therapeutic lithium 
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administration and muscle relaxants such as atracurium 
and rocuronium can interact with the Lithium sensor and 
affect the results because they contain a positively charged 
quaternary ammonia ion that can be detected by the 
electrode. The reliability of the method has been validated 
in several clinical settings and has been found to exert a 
good correlation in CO measurement with pulmonary 
artery catheter in critically ill patients with impaired left 
ventricular function after cardiac surgery and in cases of 
hyperdynamic conditions. 37,38 It is advised to recalibrate 
the device at regular intervals (e.g. every 6-8 hours), when 
acute hemodynamic changes have occurred or vasoactive 
medications have been administered to the patient. 6 
 Figure 2. Lithium dilution curve during LiDCO system 
calibration.   
The PiCCO monitoring device calculates blood 
pressure, SV and CO by arterial waveform interpretation 
and uses transpulmonary thermodilution to perform 
intermittent CO calibration. It requires a central venous 
line and a specific femoral arterial catheter. Cold saline is 
injected through the venous access site and temperature is 
measured by the femoral artery catheter. Cardiac output is 
derived using the thermodilution equation:   
                    Where Tb = blood temperature, Ti = injectate temperature, 
and K=computation constant.  
The time-temperature curve is slightly different than 
that obtained by pulmonary artery thermodilution (Fig. 3). 
For the continuous CO measurement the system needs the 
shape of the arterial waveform (dP/dt), arterial compliance, 
systemic vascular resistance (SVR), and a patient-specific 
calibration factor. Stroke volume is derived by analyzing 
the systolic portion of the arterial waveform. Vascular 
compliance is estimated from SVR and the diastolic 
portion of the arterial waveform. Recalibration is 
necessary every 6-8 hours to allow for reliable continuous 
real time results. Furthermore, PiCCO can provide 
additional information, namely the global end-diastolic 
volume (GEDV), which represents preload more reliably 
than the CVP, the intrathoracic blood volume (ITBV), the 
extravascular lung water (EVLW), and the pulmonary 
vascular permeability index (PVPI). These data are 
calculated using sophisticated mathematical formulas and 
can help the clinician discriminate between cardiogenic 
pulmonary edema and non-cardiogenic forms. 39-41 
 Figure 3. Comparison of transpulmonary thermodilution 
with PAC thermodilution showing the typical delay in 
peak temperature change  
The information provided by PiCCO technology 
appears to correlate well compared to other methods. In a 
comparative study by Hadian et al, PiCCO and LiDCO 
systems performed adequately and comparably to each 
other and PAC, whereas FloTrac system proved inferior.42 
The preload estimation by GEDV might be more accurate 
than by pulmonary capillary wedge pressure.43 In septic 
patients, owing to the periodical calibration, PiCCO can 
reliably detect CO changes induced by volume expansion 
and norepinephrine, in contrast to Flo/Trac. 44 In terms of 
clinical outcomes, Mutoh et al showed improvement in 
patients with subarachnoidal hemorrhage when monitored 
with PiCCO compared to PAC, while Uchino et al failed 
to do so in a cohort of 331 critically ill patients. 45, 46    
Since continuous measurements rely on arterial 
waveform analysis, they are subject to the inherent 
limitations regarding the presence of IABP counter-
pulsation, significant aortic regurgitation or arrhythmias. 
Moreover, the fact that PAC estimates CO of the right 
ventricle, whereas PiCCO and LiDCO that of the left 
ventricle, may produce discrepancies in cases of 
intracardiac and intrapulmonary shunts.  
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A novelty in the field of transpulmonary thermodilution 
is represented by the EV1000/VolumeView monitor which 
needs a central arterial catheter just like PiCCO and 
calculates EVLW and GEDV as well as a new variable 
named the global ejection fraction (GEF). In two recent 
trials, the new device performed at least as well as PiCCO 
and was superior in estimating GEDV.  47, 48   
Thoracic bioempedance 
Heart beat sends a certain amount of blood in the aorta 
in every cardiac cycle and transthoracic direct current 
resistance is deemed to be related to this periodical 
variation in aortic volume. The commercially available 
devices apply a high frequency current across the thorax 
and compare the amplitude of this current to that of the 
returning signal, thereby measuring the differences in 
thoracic impedance. The rate of the change of impedance 
and the ventricular ejection time are measured, and SV is 
derived from a mathematical formula. Unfortunately, the 
results can be influenced by motion artifacts, electrical 
interference, cardiac arrhythmias, heart and lung 
pathologies (anatomical deformities, pulmonary edema, 
pleural and pericardial effusions, intracardiac shunts) and 
the method has been shown inaccurate in comparison to 
thermodilution, especially in critically ill patients. 49-51  
Bioreactance 
An evolution of thoracic bioimpedance method, 
bioreactance systems (NICOM device) measure the phase 
shift in voltage across the thorax. The impedance of the 
thorax when an alternating current runs through it, consists 
of two components: a resistive impedance (due to the 
resistor properties of thorax) and a reactive impedance 
(due to the capacitor properties). The principle of function 
of bioreactance devices is the following: 4 sensors are 
attached to the ventral thoracic wall as depicted in Fig. 4. 
Each sensor carries 2 electrodes. The outer one applies 
alternating voltage of known frequency and the inner one 
records the voltage. The sensors on each side of the body 
are paired so that voltage is delivered between the outer 
electrodes of each side and recorded between the inner 
electrodes of the same side. The comparison of the two 
signals discloses to what extent a time delay, or phase shift, 
has occurred. The blood absorbs electrons causing a delay 
in the signal (phase shift), which is proportional to the 
volume of blood pumped to the aorta. This phase shift is 
then translated to flow (Fig. 5) and eventually to stroke 
volume, using the following mathematical equation:  
 Bioreactance has been shown reliable in CO measurements 
when compared with thermodilution, in various clinical 
settings including patients post-cardiac surgery and 
patients with pulmonary hypertension. 52,-54 
 
 Figure 4. Bioreactance system sensor arrangement 
 
 Figure 5. Stroke volume calculation from phase shift by 
bioreactance measuring system NICOM   
Clinical implications 
All the aforementioned methods aim at measuring SV 
and CO with acceptable accuracy, in order to provide a 
baseline estimation of the patient’s cardiovascular status 
and detect differences induced by administration of small 
amounts of fluids or inotropic and vasoactive drugs, 
allowing guidance of therapy. The devices that use the 
pulse pressure analysis method for CO monitoring, also 
calculate stroke volume variation (SVV) and pulse 
pressure variation (PPV), as these variables fluctuate in 
response to intrathoracic pressure changes during 
respiratory phases in patients on positive pressure 
mechanical ventilation. There is general agreement that 
values of SVV >10% and PPV >13% indicate that the 
patient will probably respond to the administration of 
fluids, while lower values indicate the opposite. There are 
however significant limitations since the patient must be in 
mechanical ventilation with large tidal volumes (>8 ml/kg) 
and remain in sinus rhythm. 12 
In conclusion, there are no perfect methods to perform 
a less invasive hemodynamic monitoring but a number of 
technologies are now available to help the clinician. “Pulse 
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contour methods are based on solid physical principles, 
less solid physiological models, and involve substantial 
computations.’’ 55 However, when periodically calibrated 
by thermodilution or indicator dilution, they provide 
reliable results and can indirectly calculate a variety of 
hemodynamic parameters that may prove useful in a 
clinical perspective. Nevertheless, there are still little data 
showing that any of these monitoring devices improve 
patient outcome and most importantly, physicians should 
not rely only on numerical information, but incorporate the 
patient’s clinical, hemodynamic, laboratory and imaging 
data and integrate them all under their clinical judgement.   
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